Resultados de la búsqueda 31-40 of 2935 for SC

  1. Oncología (médica) - Ensayos clínicos

    ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

  2. Oncología (médica) - Ensayos clínicos

    ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

  3. Otorrinolaringología (oído, nariz y garganta) y cirugía de cabeza y cuello - Ensayos clínicos - Mayo Clinic

    SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

  4. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the effectiveness of daratumumab SC in treating patients with monoclonal immunoglobulin deposits (PGNMID) by assessing ...

  5. Centro de Cáncer de Cabeza y Cuello - Ensayos clínicos - Mayo Clinic

    SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

  6. Oncología (médica) - Ensayos clínicos

    SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

  7. Cirugía maxilar - Médicos y departamentos - Mayo Clinic

    Bagheri SC, ed. Mandibular orthognathic surgery. In: Clinical Review of Oral and Maxillofacial Surgery. 3rd ed. Elsevier; 2025. https://www.clinicalkey.com ...

  8. Oncología (médica) - Ensayos clínicos

    ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

  9. Oncología (médica) - Ensayos clínicos

    ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

  10. Oncología (médica) - Ensayos clínicos

    ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...